BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1510977)

  • 1. Inhibition of 2,3-oxidosqualene cyclases.
    Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
    Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.
    Taton M; Benveniste P; Rahier A
    Biochem Biophys Res Commun; 1986 Jul; 138(2):764-70. PubMed ID: 3741433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
    Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
    Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules containing a tertiary amine function.
    Rahier A; Bouvier P; Cattel L; Narula A; Benveniste P
    Biochem Soc Trans; 1983 Oct; 11(5):537-43. PubMed ID: 6642064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
    Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
    Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The squalene-2,3-epoxide cyclase as a model for the development of new drugs.
    Cattel L; Ceruti M; Viola F; Delprino L; Balliano G; Duriatti A; Bouvier-Navé P
    Lipids; 1986 Jan; 21(1):31-8. PubMed ID: 3515096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.
    Viola F; Ceruti M; Cattel L; Milla P; Poralla K; Balliano G
    Lipids; 2000 Mar; 35(3):297-303. PubMed ID: 10783007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyrin synthase--cloning of oxidosqualene cyclase that catalyzes the formation of the most popular triterpene among higher plants.
    Kushiro T; Shibuya M; Ebizuka Y
    Eur J Biochem; 1998 Aug; 256(1):238-44. PubMed ID: 9746369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
    Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Cattel L
    J Med Chem; 1992 Aug; 35(16):3050-8. PubMed ID: 1501233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.
    Abe I; Bai M; Xiao XY; Prestwich GD
    Biochem Biophys Res Commun; 1992 Aug; 187(1):32-8. PubMed ID: 1520315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
    Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
    Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugated methyl sulfide and phenyl sulfide derivatives of oxidosqualene as inhibitors of oxidosqualene and squalene-hopene cyclases.
    Rocco F; Bosso SO; Viola F; Milla P; Roma G; Grossi G; Ceruti M
    Lipids; 2003 Mar; 38(3):201-7. PubMed ID: 12784859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
    Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
    Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase: a chemistry-biology interdisciplinary study of the protein's structure-function-reaction mechanism relationships.
    Wu TK; Chang CH; Liu YT; Wang TT
    Chem Rec; 2008; 8(5):302-25. PubMed ID: 18956480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyrin Biosynthesis: The Methyl-30 Group of (3S)-2,3-Oxidosqualene Is More Critical to Its Correct Folding To Generate the Pentacyclic Scaffold than the Methyl-24 Group.
    Hoshino T; Miyahara Y; Hanaoka M; Takahashi K; Kaneko I
    Chemistry; 2015 Oct; 21(44):15769-84. PubMed ID: 26351084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
    Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
    Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells.
    Mark M; Muller P; Maier R; Eisele B
    J Lipid Res; 1996 Jan; 37(1):148-58. PubMed ID: 8820110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxidosqualene cyclases in triterpenoids biosynthesis: a review].
    Chen C; Pang Y; Chen Q; Li C; Lü B
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):443-459. PubMed ID: 35234375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase.
    Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Schuber F
    Steroids; 1989; 53(3-5):363-91. PubMed ID: 2678608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.